|
UNH
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$354.2B
|
$180.82
|
+0.7%
|
+1.3%
|
-0.8%
|
-0.1%
|
-1.2%
|
+1.0%
|
|
KO
|
Consumer Defensive |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$353.3B
|
$45.98
|
-1.0%
|
-1.0%
|
-0.8%
|
+0.4%
|
+0.0%
|
-0.7%
|
|
PEP
|
Consumer Defensive |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$206.5B
|
$117.70
|
-0.5%
|
-0.6%
|
-1.0%
|
+0.0%
|
+0.3%
|
+0.1%
|
|
PANW
|
Technology |
Susquehanna |
Maintains
|
Neutral
→
Neutral
|
—
|
$170.3B
|
$23.19
|
-0.1%
|
+0.6%
|
-0.6%
|
-3.7%
|
-0.8%
|
+1.3%
|
|
DHR
|
Healthcare |
Janney Capital |
Downgrade
|
Buy
→
Neutral
|
—
|
$118.8B
|
$75.99
|
-0.5%
|
-0.3%
|
-1.0%
|
-0.1%
|
-0.5%
|
+0.1%
|
|
DHR
|
Healthcare |
Janney Montgomery Scott |
Downgrade
|
Buy
→
Neutral
|
—
|
$118.8B
|
$75.99
|
-0.5%
|
-0.3%
|
-1.0%
|
-0.1%
|
-0.5%
|
+0.1%
|
|
FTNT
|
Technology |
Susquehanna |
Maintains
|
Neutral
→
Neutral
|
—
|
$95.5B
|
$7.82
|
-0.3%
|
+0.3%
|
+0.8%
|
-5.6%
|
+0.4%
|
+1.3%
|
|
HCA
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$93.4B
|
$82.48
|
+1.2%
|
+0.2%
|
+0.1%
|
+0.9%
|
+1.5%
|
-0.0%
|
|
HCA
|
Healthcare |
Leerink Swann |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$93.4B
|
$82.48
|
+1.2%
|
+0.2%
|
+0.1%
|
+0.9%
|
+1.5%
|
-0.0%
|
|
NTES
|
Technology |
Standpoint Research |
Downgrade
|
Buy
→
Reduce
|
—
|
$73.9B
|
$60.58
|
+0.0%
|
+3.9%
|
-0.3%
|
-3.2%
|
+0.9%
|
-1.6%
|
|
IRM
|
Real Estate |
Deutsche Bank |
Downgrade
|
Hold
→
Sell
|
—
|
$36.8B
|
$35.00
|
-1.4%
|
-3.7%
|
-0.7%
|
-0.4%
|
+3.0%
|
-0.3%
|
|
CNC
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$29.0B
|
$38.12
|
+0.4%
|
+1.8%
|
+0.1%
|
-0.2%
|
-1.3%
|
+2.1%
|
|
KHC
|
Consumer Defensive |
Berenberg |
Maintains
|
Buy
→
Buy
|
—
|
$27.6B
|
$93.21
|
+0.3%
|
+0.6%
|
-1.3%
|
-1.9%
|
+0.5%
|
+0.4%
|
|
THC
|
Healthcare |
Leerink Swann |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$17.4B
|
$17.01
|
+2.9%
|
+3.2%
|
+0.5%
|
+1.8%
|
+1.8%
|
+1.5%
|
|
CHKP
|
Technology |
Susquehanna |
Maintains
|
Positive
→
Outperform
|
—
|
$13.8B
|
$113.71
|
+0.6%
|
+1.1%
|
+0.5%
|
-4.0%
|
-1.0%
|
+1.3%
|
|
UHS
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$10.7B
|
$113.50
|
-0.1%
|
-0.5%
|
-0.5%
|
+1.0%
|
+1.9%
|
+0.2%
|
|
BAH
|
Industrials |
Vertical Research |
Downgrade
|
Buy
→
Hold
|
—
|
$9.9B
|
$38.27
|
+0.0%
|
+0.7%
|
+0.9%
|
-0.9%
|
+1.1%
|
+0.5%
|
|
MOH
|
Healthcare |
Morgan Stanley |
Maintains
|
Underweight
→
Underweight
|
—
|
$9.4B
|
$68.02
|
-0.5%
|
-0.6%
|
+1.1%
|
-0.2%
|
-1.3%
|
+1.1%
|
|
ORA
|
Utilities |
JP MorganA |
Upgrade
|
Neutral
→
Overweight
|
—
|
$8.0B
|
$58.79
|
+1.2%
|
+1.6%
|
+1.1%
|
+0.5%
|
-0.1%
|
+1.1%
|
|
NICE
|
Technology |
Citigroup |
Maintains
|
Neutral
→
Neutral
|
—
|
$6.0B
|
$80.86
|
+0.2%
|
-0.8%
|
+0.5%
|
-2.8%
|
-0.7%
|
+1.8%
|